E11.22

Type 2 diabetes mellitus with diabetic chronic kidney disease

## Clinical Overview Type 2 diabetes mellitus with diabetic chronic kidney disease (CKD) is a progressive microvascular complication resulting from chronic exposure to hyperglycemia. It is defined clinically by the persistent presence of elevated urinary albumin excretion, a decline in the glomerular filtration rate (GFR), or both. Diabetic CKD is a leading cause of end-stage renal disease (ESRD) and carries a high risk for cardiovascular morbidity and mortality. ### Pathophysiology Chronic hyperglycemia triggers metabolic pathways that increase oxidative stress, inflammation, and the formation of advanced glycation end-products. These processes lead to structural changes, including glomerular basement membrane thickening, podocyte loss, and mesangial expansion. Progressive fibrosis eventually results in glomerulosclerosis and interstitial fibrosis. ### Clinical Management Management focuses on aggressive glycemic control, blood pressure regulation (ideally targeting <130/80 mmHg), and the use of renin-angiotensin-aldosterone system inhibitors (ACE inhibitors or ARBs) to reduce proteinuria. Newer therapeutic agents like SGLT2 inhibitors and GLP-1 receptor agonists have also shown significant renal protective benefits. According to ICD-10-CM guidelines, an additional code from category N18 should be used to identify the stage of chronic kidney disease.

Clinical Symptoms

  • Albuminuria
  • Peripheral edema
  • Foamy urine
  • Fatigue
  • Hypertension
  • Increased nocturia

Common Causes

  • Chronic hyperglycemia
  • Systemic hypertension
  • Genetic susceptibility
  • Obesity
  • Prolonged duration of Type 2 diabetes

Documentation & Coding Tips

Explicitly link Chronic Kidney Disease (CKD) to Diabetes Mellitus (DM) using 'with' or 'due to' terminology to ensure accurate manifestation coding.

Example: ASSESSMENT & PLAN: 68-year-old male with Type 2 Diabetes Mellitus with Stage 4 Chronic Kidney Disease (CKD), GFR currently 22 mL/min/1.73m2. DM is poorly controlled with most recent A1c of 8.9%. Patient currently on Lisinopril for renal protection and glyburide for glycemic control. Given the progression of diabetic nephropathy, we will refer to Nephrology for dialysis planning. Risk Status: Chronic, stable but high severity due to stage 4 CKD (HCC 18, HCC 137).

Billing Focus: Identify the stage of CKD (N18.1-N18.6, N18.9) as a secondary code to E11.22 to satisfy specificity requirements for claim processing.

Document all manifestations of the diabetes to capture the full complexity of the patient's condition, including associated hypertension or circulatory issues.

Example: FOLLOW-UP NOTE: Patient presents for evaluation of Type 2 Diabetes with CKD Stage 3a and Diabetic Retinopathy. Blood pressure 145/92 today. CKD is attributed to diabetic glomerulosclerosis. Current medications include Metformin and Losartan. No evidence of pedal edema today. Billing focus includes the combination of diabetic and hypertensive renal disease where applicable.

Billing Focus: Use 'with' to imply a causal relationship unless the physician states the conditions are unrelated. Ensure documentation supports medical necessity for E/M level 4 or 5 based on multi-system involvement.

Relevant CPT Codes

Related Diagnoses

Hierarchy